Myriad Genetics (MYGN) Asset Utilization Ratio (2011 - 2026)

Myriad Genetics (MYGN) has reported Asset Utilization Ratio for 16 consecutive years, with 1.2 the latest figure, recorded in Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 46.93% year-over-year to 1.2; the TTM figure through Mar 2026 stood at 1.2 (up 46.93% YoY), while the FY2025 annual figure was 0.95, up 23.41% from the prior year.
• Asset Utilization Ratio climbed to 1.2 in Q1 2026 per MYGN's latest filing, from 1.15 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.2 in Q1 2026 and bottomed at 0.53 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.76 across 5 years, with a median of 0.69 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio tumbled 35.54% — and 2025, when it soared 54.47%.
• Myriad Genetics' Asset Utilization Ratio stood at 0.56 in 2022, then climbed by 16.59% to 0.66 in 2023, then gained by 21.05% to 0.79 in 2024, then jumped by 44.69% to 1.15 in 2025, then advanced by 4.51% to 1.2 in 2026.
• Business Quant data shows MYGN's Asset Utilization Ratio at 1.2 in Q1 2026, 1.15 in Q4 2025, and 1.17 in Q3 2025.